Publications by authors named "Thangaraj Devadoss"

Claim this Profile
5
5-HT receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders.
Shvetank Bhatt, Thangaraj Devadoss, Santhepete Nanjundaiah Manjula, Jayaraman Rajangam

Curr Neuropharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of a novel quinoxaline as a new class of Nrf2 activator.
Murugesh Kandasamy, Kit-Kay Mak, Thangaraj Devadoss, Punniyakoti Veeraveedu Thanikachalam, Raghavendra Sakirolla

BMC Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 5-HT receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice.
Yeshwant Kurhe, R Mahesh, Thangaraj Devadoss

Psychopharmacology (Berl)· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats.
Shvetank Bhatt, Radhakrishnan Mahesh, Ankur Jindal, Thangaraj Devadoss

J Basic Clin Physiol Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
Shvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, Ankur Jindal

J Basic Clin Physiol Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.
Deepali Gupta, Devadoss Thangaraj, Mahesh Radhakrishnan

Behav Brain Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery.
Deepali Gupta, Mahesh Radhakrishnan, Devadoss Thangaraj, Yeshwant Kurhe

J Pharm Bioallied Sci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery.
Yeshwant Kurhe, Radhakrishnan Mahesh, Deepali Gupta, Devadoss Thangaraj

J Basic Clin Physiol Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
Yeshwant Kurhe, Radhakrishnan Mahesh, Thangaraj Devadoss

Biochem Biophys Res Commun· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice.
Shvetank Bhatt, Mahesh Radhakrishnan, Ankur Jindal, Thangaraj Devadoss, Arghya Kusum Dhar

Indian J Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression.
Arghya K Dhar, Radhakrishnan Mahesh, Ankur Jindal, Thangaraj Devadoss, Shvetank Bhatt

Chem Biol Drug Des· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Deepali Gupta, Mahesh Radhakrishnan, Yeshwant Kurhe, Devadoss Thangaraj, Visakh Prabhakar

Acta Pharmacol Sin· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-anxiety effect of a novel 5-HT₃ receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice.
Yeshwant Vijay Kurhe, Mahesh Radhakrishnan, Devadoss Thangaraj, Deepali Gupta

Indian J Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: an approach based on behavioral and biochemical investigations.
Yeshwant Kurhe, Radhakrishnan Mahesh, Deepali Gupta, Thangaraj Devadoss

Eur J Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences.
Shvetank Bhatt, Radhakrishnan Mahesh, Ankur Jindal, Thangaraj Devadoss

Pharmacol Rep· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Deepali Gupta, Mahesh Radhakrishnan, Devadoss Thangaraj, Yeshwant Kurhe

Eur J Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations.
Shvetank Bhatt, Radhakrishnan Mahesh, Ankur Jindal, Thangaraj Devadoss

Pharmacol Biochem Behav· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests.
Yeshwant Kurhe, Radhakrishnan Mahesh, Thangaraj Devadoss, Deepali Gupta

J Pharmacol Pharmacother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests.
Shvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, Ankur Kumar Jindal

Indian J Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety.
Shvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, Ankur Kumar Jindal

Indian J Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
Yeshwant Kurhe, Mahesh Radhakrishnan, Deepali Gupta, Thangaraj Devadoss

J Pharm Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
Shvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, Ankur Jindal

Indian J Exp Biol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
Shvetank Bhatt, Radhakrishnan Mahesh, Thangaraj Devadoss, Ankur Jindal

Indian J Exp Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.
Baldev Kumar, Ankur Jindal, Dilip Kumar Pandey, Shvetank Bhatt, Thangaraj Devadoss

Indian J Exp Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis